Skip to main content
Clinical Trials/TCTR20190907003
TCTR20190907003
Completed
Phase 1

The effect of oxygen therapy to reduce blood loss in postpartum period: A randomized controlled trial

Khon Kaen Hospital0 sites76 target enrollmentSeptember 7, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Postpartum vaginal blood loss
Sponsor
Khon Kaen Hospital
Enrollment
76
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 7, 2019
End Date
February 28, 2019
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Maternal age ≥ 18 years old
  • Singleton pregnancy
  • 37 complete weeks to 41\+6 weeks of gestational age
  • Normal vaginal delivery with or without episiotomy
  • Estimate neonatal birth weight 2,500\-4,000 gm by measuring tape (Johnson's formula) or ultrasound (Hadlock)

Exclusion Criteria

  • Prior of postpartum hemorrhage, hypertension in pregnancy, bleeding during pregnancy, polyhydramnios, uterine anomalies, and/or abnormal placentation
  • Maternal or intrauterine infection
  • Coagulopathy or anticoagulant drugs used
  • Abnormal progression of labor (prolongation disorder, protraction disorder, arrest disorder, and precipitate labor).

Outcomes

Primary Outcomes

Not specified

Similar Trials